Maximus, Inc. (NYSE:MMS) Shares Acquired by Cerity Partners LLC

Cerity Partners LLC lifted its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 6.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 119,267 shares of the health services provider's stock after purchasing an additional 7,352 shares during the period. Cerity Partners LLC owned about 0.21% of Maximus worth $8,931,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of Maximus by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock worth $488,829,000 after acquiring an additional 205,564 shares during the period. Geode Capital Management LLC increased its holdings in Maximus by 1.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider's stock worth $142,109,000 after purchasing an additional 21,532 shares during the period. Van Berkom & Associates Inc. raised its position in Maximus by 8.5% during the 4th quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock valued at $93,792,000 after purchasing an additional 98,264 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Maximus by 7.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock worth $74,700,000 after buying an additional 71,598 shares during the period. Finally, Norges Bank bought a new position in shares of Maximus during the 4th quarter worth $71,443,000. Hedge funds and other institutional investors own 97.21% of the company's stock.

Remove Ads

Maximus Stock Up 0.1 %

Shares of MMS traded up $0.08 during trading hours on Wednesday, hitting $68.17. The company had a trading volume of 27,723 shares, compared to its average volume of 675,937. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The company has a market capitalization of $3.86 billion, a PE ratio of 14.66 and a beta of 0.68. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.97. The company's fifty day moving average price is $67.71 and its two-hundred day moving average price is $75.82.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. As a group, equities analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.76%. The ex-dividend date of this dividend is Thursday, May 15th. Maximus's dividend payout ratio is currently 25.81%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a report on Friday, February 14th. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target for the company in a research report on Thursday, January 2nd.

Insider Transactions at Maximus

In other news, insider Ilene R. Baylinson sold 14,500 shares of the business's stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.